Aspirin may decrease the risk for developing high-grade prostate cancer
the ONA take:
According to new findings presented at the 13th Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research in New Orleans, Louisiana, the use of aspirin and other other non-steroidal anti-inflammatory drugs (NSAIDs) were associated with a decreased risk for developing an aggressive form of prostate cancer in patients who had a negative biopsy despite an increased prostate specific antigen (PSA).
The researchers used patients from the REDUCE trial, which studied if dutasteride, a 5-alpha reductase inhibitor, lowers the risk for developing prostate cancer.
Of the 6,390 participants with a PSA between 2.5 ng/mL and 10 ng/mL and a negative biopsy prior to the study, 50% were aspirin/NSAID nonusers, 21% were aspirin users, 18% were NSAID users, and 11% were users of both drugs. They found that aspirin and/or NSAID use decreased the risk for developing prostate cancer by 14%, and after adjusting for confounding factors, 13%.
Furthermore, they found that aspirin and/or NSAID use lowered the risk of high-grade disease by 17%. No link was observed with low-grade prostate cancer. Results were similar among patients from different continents.
Aspirin and other other NSAIDs were associated with a decreased risk for aggressive prostate cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|